These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
298 related articles for article (PubMed ID: 29374982)
1. Protecting UK adolescents and adults against meningococcal serogroup B disease. Vyse A; Ellsbury G; Madhava H Expert Rev Vaccines; 2018 Mar; 17(3):229-237. PubMed ID: 29374982 [TBL] [Abstract][Full Text] [Related]
2. 4CMenB journey to the 10-year anniversary and beyond. Abitbol V; Martinón-Torres F; Taha MK; Nolan T; Muzzi A; Bambini S; Borrow R; Toneatto D; Serino L; Rappuoli R; Pizza M Hum Vaccin Immunother; 2024 Dec; 20(1):2357924. PubMed ID: 38976659 [TBL] [Abstract][Full Text] [Related]
3. A review of the immunogenicity, safety and current recommendations for the meningococcal serogroup B vaccine, MenB-FHbp. Burman C; Alderfer J; Snow VT J Clin Pharm Ther; 2020 Apr; 45(2):270-281. PubMed ID: 31820483 [TBL] [Abstract][Full Text] [Related]
4. Introduction of a second MenB vaccine into Europe - needs and opportunities for public health. Findlow J; Nuttens C; Kriz P Expert Rev Vaccines; 2019 Mar; 18(3):225-239. PubMed ID: 30821535 [TBL] [Abstract][Full Text] [Related]
5. Parental awareness and utilization of meningococcal serogroup B vaccines in the United States. Srivastava A; Dempsey A; Galitsky A; Fahimi M; Huang L BMC Public Health; 2020 Jul; 20(1):1109. PubMed ID: 32664872 [TBL] [Abstract][Full Text] [Related]
6. Vaccination with a multicomponent meningococcal B vaccine in prevention of disease in adolescents and young adults. Nolan T; O'Ryan M; Wassil J; Abitbol V; Dull P Vaccine; 2015 Aug; 33(36):4437-45. PubMed ID: 26187261 [TBL] [Abstract][Full Text] [Related]
7. Use of Serogroup B Meningococcal Vaccines in Adolescents and Young Adults: Recommendations of the Advisory Committee on Immunization Practices, 2015. MacNeil JR; Rubin L; Folaranmi T; Ortega-Sanchez IR; Patel M; Martin SW MMWR Morb Mortal Wkly Rep; 2015 Oct; 64(41):1171-6. PubMed ID: 26492381 [TBL] [Abstract][Full Text] [Related]
8. Clinical experience with the meningococcal B vaccine, Bexsero(®): Prospects for reducing the burden of meningococcal serogroup B disease. Watson PS; Turner DP Vaccine; 2016 Feb; 34(7):875-80. PubMed ID: 26686570 [TBL] [Abstract][Full Text] [Related]
9. Randomized Trial of 2 Schedules of Meningococcal B Vaccine in Adolescents and Young Adults, Canada Langley JM; Gantt S; Quach C; Bettinger JA; Halperin SA; Mutch J; McNeil SA; Ward BJ; MacKinnon-Cameron D; Ye L; Marty K; Scheifele D; Brown E; Alcantara J; Emerg Infect Dis; 2020 Mar; 26(3):454-462. PubMed ID: 32091358 [TBL] [Abstract][Full Text] [Related]
10. Potential Coverage of the 4CMenB Vaccine against Invasive Serogroup B Mulhall RM; Bennett D; Cunney R; Borrow R; Lucidarme J; Findlow J; Jolley KA; Bray J; Maiden MCJ; Moschioni M; Serino L; Stella M; Medini D mSphere; 2018 Aug; 3(4):. PubMed ID: 30135218 [No Abstract] [Full Text] [Related]
11. Parental awareness of Meningococcal B vaccines and willingness to vaccinate their teens. Basta NE; Becker AB; Li Q; Nederhoff D Vaccine; 2019 Jan; 37(4):670-676. PubMed ID: 30587431 [TBL] [Abstract][Full Text] [Related]
12. Meningococcal group B vaccines. Findlow J Hum Vaccin Immunother; 2013 Jun; 9(6):1387-8. PubMed ID: 23732894 [TBL] [Abstract][Full Text] [Related]
13. Use of Serogroup B Meningococcal Vaccines in Persons Aged ≥10 Years at Increased Risk for Serogroup B Meningococcal Disease: Recommendations of the Advisory Committee on Immunization Practices, 2015. Folaranmi T; Rubin L; Martin SW; Patel M; MacNeil JR; MMWR Morb Mortal Wkly Rep; 2015 Jun; 64(22):608-12. PubMed ID: 26068564 [TBL] [Abstract][Full Text] [Related]
14. MenB-FHbp Meningococcal Group B Vaccine (Trumenba Shirley M; Taha MK Drugs; 2018 Feb; 78(2):257-268. PubMed ID: 29380290 [TBL] [Abstract][Full Text] [Related]
15. Susceptibility of Meningococcal Strains Responsible for Two Serogroup B Outbreaks on U.S. University Campuses to Serum Bactericidal Activity Elicited by the MenB-4C Vaccine. Rossi R; Beernink PT; Giuntini S; Granoff DM Clin Vaccine Immunol; 2015 Dec; 22(12):1227-34. PubMed ID: 26424832 [TBL] [Abstract][Full Text] [Related]
16. Meningococcal Carriage Evaluation in Response to a Serogroup B Meningococcal Disease Outbreak and Mass Vaccination Campaign at a College-Rhode Island, 2015-2016. Soeters HM; Whaley M; Alexander-Scott N; Kanadanian KV; MacNeil JR; Martin SW; McNamara LA; Sicard K; Vanner C; Vuong J; Wang X; Bandy U; Patel M; Clin Infect Dis; 2017 Apr; 64(8):1115-1122. PubMed ID: 28158417 [TBL] [Abstract][Full Text] [Related]
17. Cost calculator for mass vaccination response to a US college campus outbreak of serogroup B meningococcal disease. La EM; Talbird SE; Kanadanian KV; Huang L; Fain J; Srivastava A Hum Vaccin Immunother; 2019; 15(4):978-986. PubMed ID: 30526279 [TBL] [Abstract][Full Text] [Related]
18. Lessons from mass vaccination response to meningococcal B outbreaks at US universities. Alderfer J; Isturiz RE; Srivastava A Postgrad Med; 2020 Sep; 132(7):614-623. PubMed ID: 32476532 [TBL] [Abstract][Full Text] [Related]
19. Serum bactericidal activity against circulating and reference strains of meningococcal serogroup B in the United States: A review of the strain coverage of meningococcal serogroup B (MenB) vaccines in adolescents and young adults. Presa J; Burman C; Tort MJ; Cane A; Bocchini JA Hum Vaccin Immunother; 2023 Dec; 19(1):2212570. PubMed ID: 37257838 [TBL] [Abstract][Full Text] [Related]
20. Clinical data supporting a 2-dose schedule of MenB-FHbp, a bivalent meningococcal serogroup B vaccine, in adolescents and young adults. Beeslaar J; Absalon J; Balmer P; Srivastava A; Maansson R; York LJ; Perez JL Vaccine; 2018 Jun; 36(28):4004-4013. PubMed ID: 29861182 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]